🇺🇸 FDA
Patent

US 7612203

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

granted A61PA61P3/06

Quick answer

US patent 7612203 (Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P3/06